#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
John Babich Email
Director, President, Chief Scientific Officer . Ratio Therapeutics
How to contact John Babich
Join and see John's contact info for free!Current Roles
Employees:
38Revenue:
$3.8MAbout
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie \theranostics\. The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.Ratio Therapeutics Address
One Design Center PlaceBoston, MA
United States